Aviceda Therapeutics, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

Aviceda Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $75 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Aviceda Therapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2019

SEC CIK1824762

What does Aviceda Therapeutics do?

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $75 million sold (2025).

Frequently asked questions about Aviceda Therapeutics

Where is Aviceda Therapeutics headquartered?

Aviceda Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Aviceda Therapeutics do?

Aviceda Therapeutics, Inc. is a biotechnology company.

When was Aviceda Therapeutics founded?

The earliest incorporation on record for Aviceda Therapeutics, Inc. is in 2019, according to public company registers.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences